Ensure that your peptides are sourced from a licensed 503a compounding pharmacy that conducts third-party testing for purity and sterility
If you have used this app to generate your own risk assessment, you can show it to your doctor to help communicate your level of risk
Last updated: April 20, 2026 Semaglutide vs Tirzepatide vs Retatrutide (2026): Head-to-Head Clinical Data, Dosing & Access Researched and written by Garret Grant Founder & Lead Researcher, B.S
Ultimately, the decision comes down to individual patient response, treatment goals, and any underlying health conditions
Treatment with oral semaglutide led to a greater reduction in the inflammatory marker C-reactive protein compared to the sodium-glucose co-transporter-2 inhibitor (SGLT-2i) empagliflozin, without any difference in reduction in body weight between compounds (28)
I found myself at my unhealthiest and most miserable